March 24, 2026

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: A Compelling 43.57% Upside Potential Amid Biotech Developments

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stands out in the biotech industry for its innovative approach to tackling intractable diseases. Headquartered in Pasadena, California, this $7.94 billion..

Evolent Health, Inc (EVH)

⚠️ No article content returned.

..

Pacira BioSciences (PCRX): Exploring Growth Potential Amidst a Strong Analyst Consensus

Pacira BioSciences, Inc. (NASDAQ: PCRX), a key player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, offers a compelling opportunity for..

Viridian Therapeutics, Inc. (VRDN): Investor Outlook Reveals 51% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company based in Waltham, Massachusetts, is gaining attention in the investor community due to its impressive growth potential and..

agilon health, inc. (AGL) Stock Analysis: Exploring the 114.63% Potential Upside Opportunity

For investors with an eye on the healthcare sector, agilon health, inc. (AGL) presents a unique opportunity within the Medical Care Facilities industry. As a company..

Azenta, Inc. (AZTA) Stock Analysis: Exploring the 89% Potential Upside

Investors seeking opportunities in the healthcare sector may want to turn their attention to Azenta, Inc. (NASDAQ: AZTA), a company that is making strides in the..

Tandem Diabetes Care, Inc. (TNDM): Investor Outlook on a Medical Device Innovator with 21% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is a key player in the healthcare sector, specifically within the medical devices industry, focusing on advanced technology solutions for..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Promising 93.96% Upside Sparks Investor Interest

For investors seeking opportunities in the healthcare sector, Vera Therapeutics, Inc. (NASDAQ: VERA) presents a compelling prospect. Specializing in the biotechnology industry, this California-based company is..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eyeing a 47% Potential Upside with Biotech Innovations

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a prominent player in the biotechnology sector, is garnering significant attention from investors due to its innovative approach in developing therapeutic..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 207% Upside Potential Amidst Strong Revenue Growth

MannKind Corporation (NASDAQ: MNKD) stands at an intriguing crossroads for investors seeking exposure to the biotechnology sector. With its focus on innovative solutions for chronic diseases..

Structure Therapeutics Inc. (GPCR) Stock Analysis: A Biotech Play with 122% Potential Upside

For investors seeking high-reward opportunities in the biotechnology sector, Structure Therapeutics Inc. (NASDAQ: GPCR) presents a compelling case. With an impressive potential upside of 122.18%, according..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential Upside of 77.64% Amidst Volatility

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, operates within the niche of specialty and generic drug manufacturing. Headquartered in Dublin, Ireland,..

Liquidia Corporation (LQDA) Investor Outlook: Analysts See 40% Upside Potential in Biopharma Innovator

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company at the forefront of rare cardiopulmonary disease treatment, has captured investors’ attention with its potential for significant stock price..

U.S. Physical Therapy, Inc. (USPH) Investor Outlook: Exploring a 38.30% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH) stands as a noteworthy player in the healthcare sector, specifically in the medical care facilities industry. Headquartered in Houston, Texas,..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: A 52.69% Potential Upside Beckons Investors

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is a name that resonates well within the healthcare sector, particularly among those tracking the dynamic biotechnology industry. With a market..

Mesoblast Limited (MESO) Stock Analysis: A Biotech with 149% Upside Potential Amidst Rapid Revenue Growth

Investors with a keen eye on the biotechnology sector might find Mesoblast Limited (NASDAQ: MESO) an intriguing opportunity. Headquartered in Melbourne, Australia, Mesoblast is a prominent..

Artivion, Inc. (AORT) Stock Analysis: Exploring a Potential 44% Upside in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT) stands as a notable player within the healthcare sector, specifically in the medical devices industry. Headquartered in Kennesaw, Georgia, Artivion specializes in..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 119% Potential Upside in the Medical Device Sector

NovoCure Limited (NASDAQ: NVCR), a prominent player in the medical device sector, is making waves with its innovative tumor treating fields (TTFields) technology. Headquartered in Baar,..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Navigating a 50.81% Potential Upside

Investors with a keen eye for opportunity should pay close attention to Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a dynamic player in the healthcare sector, known for..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Evaluating the Challenges and Opportunities

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of..

Search

Funds

March 24, 2026

Search

Funds

March 24, 2026

FTSE 100

Funds